extracorporeal photopheresis (ecp) ECP is an immunotherapy approved for cutaneous T-cell lymphoma and recommended for patients with blood involvement. That is, CTCL cells …

Extracorporeal photopheresis (ECP), also known as extracorporeal photoimmunotherapy or photochemotherapy, is a leukapheresis-based therapy which was initially used in patients with …

Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute …

2017年12月7日 · Introduction: Extracorporeal photopheresis (ECP) is an immunotherapeutic procedure approved in the US for the treatment of skin manifestations of cutaneous T-cell …

Although ECP was initially developed for use in CTCL, it has shown promising efficacy in a number of other severe and difficult-to-treat conditions, most widely in graft-versus-host …

Extracorporeal photopheresis (ECP) alone or in combination therapy is effective for treatment of leukemic cutaneous T-cell lymphoma (L-CTCL), but its mechanism(s) of action remain …

Extracorporeal Photopheresis (ECP) is a leading treatment option that is widely used for CTCL today. This review is made to figure out the efficacy and safety of ECP as Immunotherapy for …

2018年8月27日 · Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome …

2024年6月6日 · Extracorporeal photopheresis (ECP) is a leukapheresis-based therapeutic procedure that has been approved by the US Food and Drug Administration (FDA) for the …

2023年11月14日 · Extracorporeal photopheresis (ECP), also called simply "photopheresis," extracorporeal photoimmune therapy, or photochemotherapy is a treatment used for some …